InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Browse the full record of transactions filed by PAKIANATHAN DEEPIKA, Director. Director active across 3 companies, notably Pardes Biosciences, INC.. Cumulatively, 6 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €2m. Activity tracked since 23 December 2021. The latest transaction was disclosed on 8 June 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
322,825 shares@ US$6.50331.13% mcap100.0% of flowCommon StockSEC:0000899243-22-021957:0
9,852 shares0Ordinary SharesSEC:0001415889-22-004336:0
30,000 shares0Class A Common StockSEC:0001213900-21-068105
30,000 shares0Class A Common StockSEC:0001213900-21-068105:0
52,500 shares0Class A Common StockSEC:0001213900-21-067726
52,500 shares0Class A Common StockSEC:0001213900-21-067726:0
6 of 6 declarations
About PAKIANATHAN DEEPIKA
Deepika Pakianathan serves as a Board Member at PARDES BIOSCIENCES, INC., Theravance Biopharma, Inc., and Karyopharm Therapeutics Inc. She brings expertise in strategy and innovation. In her role, she contributes to the strategic direction and oversight of the companies' operations.
